Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

GABA-B antagonists from Novartis

April 30, 1997

Pharmacia & Upjohn prepares potent and selective dopamine D4 antagonist

April 29, 1997

SKB reports neuronal calcium channel antagonists

April 29, 1997

Sanofi describes selective NK3 receptor antagonists

April 29, 1997

Delta-opioid agonists/antagonists described by SmithKline Beecham

April 29, 1997

Parke-Davis SAR studies lead to potent, selective D4 antagonist

April 28, 1997

Discovery of potent and selective mu-opiate receptor agonists

April 28, 1997

Mimetix initiates clinical trial with injectable form of naproxen

April 25, 1997

CoCensys discovers potent, water-soluble allosteric modulators of GABA-A receptor

April 25, 1997

Neurotrophic/neuroprotective agents described by Synthelabo

April 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...